Co-Diagnostics Joins SEAR Advanced TB Diagnostics Workshop
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 18 2025
0mins
Source: Newsfilter
- Collaboration Opportunity: Co-Diagnostics' joint venture CoSara has been invited to participate in the Advanced TB Diagnostics Course from December 15-19, 2025, in Chennai, India, aimed at enhancing tuberculosis detection capabilities in the Southeast Asian region, thereby increasing the company's influence in global health.
- Industry Collaboration: The workshop, hosted by ICMR-NIRT and the McGill International TB Centre, gathers experts from organizations like WHO and the Gates Foundation, showcasing Co-Diagnostics' potential for technological innovation in tuberculosis detection.
- Technology Showcase: The event will feature technology pitches from industry innovators, emphasizing emerging diagnostic solutions, which not only provides Co-Diagnostics a platform to showcase its technology but also potentially attracts partners and investors.
- Policy Impact: By exploring cost-effectiveness modeling and evidence-based policy development, the workshop will offer critical market insights for Co-Diagnostics, aiding the company in addressing future demands in tuberculosis detection through informed product development and market strategies.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
